ArticleCureus2025
Outcomes of Drug-Eluting Balloon-Only Percutaneous Coronary Intervention in Elderly Patients With Acute Coronary Syndrome and High Bleeding Risk.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explores the outcomes of drug-eluting balloon (DEB)-only percutaneous coronary intervention (PCI) in elderly patients with acute coronary syndrome and high bleeding risk, comparing it to traditional drug-eluting stent (DES)-only PCI. We conducted a retrospective study at Hayatabad Medical Complex, Peshawar, from June 2023 to June 2024, involving 300 patients aged 65-90 years. Half underwent DEB-only PCI, and half received DES-only PCI. Key outcomes assessed included ischemic events, major bleeding, PCI success rates, and the influence of pre-PCI bleeding risk. Data analysis using IBM SPSS Statistics for Windows, Version 25.0 (Released 2017; IBM Corp., Armonk, NY, USA) revealed no significant difference in ischemic events (30% for DEB vs. 38.7% for DES), major bleeding (13.3% vs. 12.0%), or PCI success rates (86.7% vs. 92%). However, pre-PCI bleeding risk significantly influenced post-PCI bleeding. Overall, DEB-only PCI demonstrated comparable efficacy to DES-only PCI, suggesting it is a viable option for elderly patients with high bleeding risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.